Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Keith Crandell

AddedMar 31, 2024

UpdatedMay 31, 2026

Keith Crandell

Keith Crandell

Co-Founder, Arch Venture Partners

Keith Crandell's Career

Arch Venture Partners

Arch Venture Partners

Chicago, IL, US

Co-Founder

908 Devices

Boston, MA, US

Board Member· Board

Twist Bioscience

Twist Bioscience

San Francisco, CA, US

Board Member· Board

Pixelexx Systems

Pixelexx Systems

Chicago, IL, US

Board Member· Board

Permeon Biologics

Permeon Biologics

Cambridge, MA, US

Board Member· Board

Ciespace

Santa Clara, CA, US

Board Member· Board

Cytrellis Biosystems

Cytrellis Biosystems

Woburn, MA, US

Board Member· Board

Ultivue

Cambridge, MA, US

Board Member· Board

Arbor Biotechnologies

Arbor Biotechnologies

Cambridge, MA, US

Board Member· Board

Nanosys

Milpitas, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Keith Crandell's Career

Arch Venture Partners

Arch Venture Partners

Investment FirmInvestment Firm671986Chicago, IL, US

Co-Founder

Recent news

Oratomic raises $300M to build a viable quantum computer that needs only 20K qubitsTechCrunch · 2026

Leadership at Arch Venture Partners

Robert NelsenCo-Founder

Clinton BybeeCo-Founder

Steve LazarusCo-Founder

Similar to Arch Venture Partners

Atlas VentureCambridge, MA, USest. 1980Atlas VentureCambridge, MA, US · est. 1980

Atlas Ventures LLC: A US-based venture capital firm investing in early-stage tech and life science startups.

Investment Firm29

Archer Venture CapitalLos Angeles, CA, USest. 2010Archer Venture CapitalLos Angeles, CA, US · est. 2010

Archer Venture Capital: An investment and advisory firm for start-ups and entrepreneurs.

Investment Firm8

Arch Development PartnersChicago, IL, USest. 2001Arch Development PartnersChicago, IL, US · est. 2001

ARCH Development Partners, L.L.C. is a US-based venture capital firm serving various clients.

Investment Firm30

Archetype Venturesward area of Tokyo, Tokyo, JPest. 2013Archetype Venturesward area of Tokyo, Tokyo, JP · est. 2013

Archetype Ventures: A venture capital firm specializing in seed and early-stage B2B investments, with a focus on the domestic internet industry.

Investment Firm33

908 Devices

Public$66.8M2272012Boston, MA, US

Board Member· Board

Leadership at 908 Devices

J. Michael RamseyCo-Founder

Andy BartfayCo-Founder

Fenel EloiBoard Member

Nicolas BarthelemyBoard Member

Christopher PettyCo-Founder

Mark SpotoBoard Member

Twist Bioscience

Twist Bioscience

Public$553.1M9892013San Francisco, CA, US

Board Member· Board

Leadership at Twist Bioscience

Bill BanyaiBoard Member

Bob RagusaBoard Member

Emily LeproustBoard Member

Rob ChessBoard Member

Xiaoying MaiBoard Member

Melissa StarovasnikBoard Member

Similar to Twist Bioscience

Switchback SystemsSan Francisco, CA, USDNA Synthesisest. 2019Switchback SystemsSan Francisco, CA, US · est. 2019

Switchback Systems, a San Francisco-based software startup, specializes in efficient, scalable DNA synthesis platforms.

Seed · $7.1M14

Ansa BiotechnologiesEmeryville, CA, USDNA Synthesisest. 2018Ansa BiotechnologiesEmeryville, CA, US · est. 2018

Ansa Biotechnologies: Pioneering enzyme-based, efficient DNA synthesis.

Series A · $83.4M82

SynthegoRedwood City, CA, USCrispr Kits, Gene Editingest. 2012SynthegoRedwood City, CA, US · est. 2012

US-based Synthego Corp. provides software solutions for biological research, primarily serving California.

Series E · $460.5M322

Ginkgo BioworksBoston, MA, USOrganism Designest. 2009Ginkgo BioworksBoston, MA, US · est. 2009

Ginkgo Bioworks: Engineering biology, designing custom organisms for diverse markets.

Public · $1.6B1.3k

Pixelexx Systems

Pixelexx Systems

Pre-Seed$2.2M72008Chicago, IL, US

Board Member· Board

Leadership at Pixelexx Systems

Stuart SolinFounder

Similar to Pixelexx Systems

Vita ImagingFremont, CA, USMedical Devicesest. 2019Vita ImagingFremont, CA, US · est. 2019

Vita Imaging, a Fremont-based manufacturer, develops advanced medical devices for accurate, rapid cancer detection.

Diagnostic PhotonicsChicago, IL, USImaging, Medical Devicesest. 2008Diagnostic PhotonicsChicago, IL, US · est. 2008

Chicago-based Diagnostic Photonics creates real-time, advanced imaging tech for tissue evaluation.

Series B · $3M30

NanoMedTrixCoralville, IA, USCancer Treatment, Nanoparticlesest. 2012NanoMedTrixCoralville, IA, US · est. 2012

NanoMedTrix: Pioneering nanoparticle tech for biomedical imaging and targeted cancer treatment since 2012.

Angel · $185k2

Imago SystemsLansdowne, VA, USMedical Imagingest. 2015Imago SystemsLansdowne, VA, US · est. 2015

Imago Systems: Advanced medical imaging and visualization software for accurate early detection of abnormalities.

Angel · $370k17

Permeon Biologics

Permeon Biologics

Seed$2.5M112011Cambridge, MA, US

Board Member· Board

Leadership at Permeon Biologics

Patrick GageBoard Member

Katherine BowdishBoard Member

John EdwardsBoard Member

Similar to Permeon Biologics

Purinomia BiotechWoburn, MA, USBiologicals, Drug Developmentest. 2017Purinomia BiotechWoburn, MA, US · est. 2017

Purinomia Biotech: MA-based innovator in biologicals and drug development for diverse diseases.

ProFound TherapeuticsCambridge, MA, USTherapeuticsest. 2022ProFound TherapeuticsCambridge, MA, US · est. 2022

ProFound Therapeutics: Innovating impactful disease understanding and therapeutic creation.

Series A · $75M35

Cogent BiosciencesWaltham, MA, USBiotech, Therapiesest. 2014Cogent BiosciencesWaltham, MA, US · est. 2014

US-based Cogent Biosciences develops biotech solutions for genetically driven diseases.

Public · $692.7M138

ProThera BiologicsProvidence, RI, USDiagnostics, Therapeuticsest. 2001ProThera BiologicsProvidence, RI, US · est. 2001

Prothera Biologics, based in East Providence, US, develops and provides theranostic treatments for sepsis and cancer.

Pre-Seed · $750k6

Ciespace

Series B$6M112010Santa Clara, CA, US

Board Member· Board

Leadership at Ciespace

Kenji ShimadaFounder

Thomas CurryBoard Member

Similar to Ciespace

BytespacePalo Alto, CA, USSoftwareest. 2022BytespacePalo Alto, CA, US · est. 2022

Bytespace, founded in 2022, is a Palo Alto-based software company.

CogniticsBoise, ID, USProgramming, Softwareest. 2008CogniticsBoise, ID, US · est. 2008

Cognitics, Inc.: Expert software product developer and computer programming services since 2008.

Seed · $7.5k12

Collaborative Software InitiativePortland, OR, USSoftwareest. 2007Collaborative Software InitiativePortland, OR, US · est. 2007

An innovative software company specializing in the development and commercialization of enterprise solutions.

Series C · $8.8M30

Citius SoftwareLakeway, TX, USSoftwareest. 2009Citius SoftwareLakeway, TX, US · est. 2009

Lakeway-based software company providing solutions for Government and Service Industry.

Angel · $250k30

Cytrellis Biosystems

Cytrellis Biosystems

Series C$86.1M1162012Woburn, MA, US

Board Member· Board

Leadership at Cytrellis Biosystems

Doug LevinsonFounder

John McDonoughBoard Member

Frederick BeddingfieldBoard Member

Michael PetersonBoard Member

Amit MunshiBoard Member

R Jason RicheyCEO

Similar to Cytrellis Biosystems

Cellutions BiosystemsDuluth, GA, USMedical Devicesest. 2002Cellutions BiosystemsDuluth, GA, US · est. 2002

Cellutions develops proprietary medical devices for minimally invasive cellulite treatments.

Pre-Seed · $22.4M375

Syntr Health TechnologiesIrvine, CA, USMedical Devicesest. 2016Syntr Health TechnologiesIrvine, CA, US · est. 2016

Syntr Health Technologies: Innovating body contouring devices, founded by biomedical experts.

Series A · $2.2M8

SeaStar MedicalAnn Arbor, MI, USMedical Devicesest. 2007SeaStar MedicalAnn Arbor, MI, US · est. 2007

CytoPherx Inc. offers proprietary medical devices for treating inflammation-based diseases.

Series C · $50.2M5

jCyteNewport Beach, CA, USCell Therapyest. 2012jCyteNewport Beach, CA, US · est. 2012

US-based jCyte pioneers in progenitor cell technology for retinal diseases, offering non-surgical jCell treatment.

Series A · $3.9M11

Ultivue

Series D$107.3M562015Cambridge, MA, US

Board Member· Board

Leadership at Ultivue

Fenel EloiBoard Member

Ralf JungmannCo-Founder

David WaltCo-Founder

Peng YinCo-Founder

Adam WieschhausBoard Member

Martin MadausBoard Member

Similar to Ultivue

Altos LabsRedwood City, CA, USCell Therapiesest. 2021Altos LabsRedwood City, CA, US · est. 2021

Altos Labs, Inc.: An American biotech firm pioneering life extension therapies via specialized cell therapies since 2022.

Series A · $3B500

Zinnia TechnologiesChicago, IL, USCare Toolsest. 2019Zinnia TechnologiesChicago, IL, US · est. 2019

Zinnia Technologies: A leading care tool provider, offering rewarding careers and a balanced work-life culture.

Pre-Seed · $120k6

ClearLight BiotechnologiesSunnyvale, CA, US3D Imaging, Tissue Analysisest. 2015ClearLight BiotechnologiesSunnyvale, CA, US · est. 2015

ClearLight Biotechnologies: Innovating non-destructive 3D tissue analysis for clinical research.

Seed · $12.3M11

Upstream BioWaltham, MA, USAntibody Therapyest. 2021Upstream BioWaltham, MA, US · est. 2021

Upstream Bio: Clinical-stage developer of monoclonal antibody therapy for severe asthma.

Series B · $408M17

Arbor Biotechnologies

Arbor Biotechnologies

Series B$230.6M1702016Cambridge, MA, US

Board Member· Board

Leadership at Arbor Biotechnologies

David ScottCo-Founder

Chen YuBoard Member

Feng ZhangCo-Founder

Paul MeisterBoard Member

Winston YanCo-Founder

Nanosys

Series B$246.7M1202001Milpitas, CA, US

Board Member· Board

Leadership at Nanosys

Jason HartloveBoard Member

Steve OesterleBoard Member

Bruce BerkoffBoard Member

Greg YurekBoard Member

Narbeh DerhacobianBoard Member

Steve GoldbyBoard Member

Keith Crandell's Similar Executives & Operators

Lau Eng BoonBoard Member · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

Soemantri BrodjonegoroBoard Member · Bukalapak

Achmad ZakyCo-Founder · Bukalapak

Nugroho HerucahyonoCo-Founder · Bukalapak

Chi-hyung SongBoard Member · Dunamu

Haeil YiCo-Founder · Dunamu

Hyoung-nyon KimCo-Founder · Dunamu

People Similar to Keith Crandell

Jeffrey HarrisBoard Member · National Venture Capital Association

Barry EggersBoard Member · National Venture Capital Association

Charles HudsonFounder · Precursor Ventures

Byron DeeterUnknown · SendGrid

Gavin ChristensenFounder · Kickstart

Nnamdi OkikeCo-Founder · 645 Ventures